Drug intelligence / Profile preview

4,7-dioxosebacic acid

Development stage: Unknown
Modality: Small Molecules

Overview

4,7-Dioxosebacic acid is a small molecule dicarboxylic acid with the molecular formula C10H14O6 and a molecular weight of approximately 230.21 g/mol[1][2]. It is also known as 4,7-dioxodecanedioic acid. This compound is classified as an experimental drug and has been studied primarily for its biochemical interactions rather than clinical use. Its main known mechanism of action is inhibition of delta-aminolevulinic acid dehydratase (ALAD), an enzyme involved in the biosynthesis of tetrapyrroles such as heme[2]. By inhibiting ALAD, it may interfere with porphyrin and heme metabolism.

Other names: 4,7-dioxodecanedioic acid

Targets

ALAD (5-aminolevulinic acid dehydratase)

Beyond the preview

Go deeper on 4,7-dioxosebacic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4,7-dioxosebacic acid.

Explore the full profile